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Opposite effects of urea on hemoglobin-oxygen affinity in anemia of
chronic renal failure. We studied the action of urea on the spin-spin
relaxation rate of 2,3-diphosphoglycerate (2,3-DPG) phosphorus atoms in
normal and uremic erythrocytes. At concentrations from 10 to 60 mM,
urea increased the relaxation rates of 2,3-DPG P-3 phosphorus atoms.
This evidenced a stronger binding of 2,3-DPG to hemoglobin (Hb),
suggesting that the deoxyform of Hb was stabilized. This hypothesis was
confirmed by measurements of the association constant of oxygen to
hemoglobin (K) in normal erythrocytes in presence of urea concentrations
in the range of those observed in uremic patients (30 mM). Indeed, the
observed decrease in K suggests that the T structure of hemoglobin is
stabilized. By contrast, with higher urea concentrations (120 mM), mea-
surements of P50 showed an increase in the hemoglobin affinity for oxygen
(decrease in P50). Moreover, the relaxation rates of 2,3-DPG P-3 phos-
phorus atoms were not modified, which is consistent with the simultaneous
increase of K. This may be attributed to the formation of carbamylated
hemoglobin in presence of urea. These results suggest two opposite effects
of urea on Hb-02 affinity: the first reinforces 2,3-DPG-Hb binding and
leads to a decrease in 02 affinity; the second, mediated by carbamylation
of Hb, hinders the binding of 2,3-DPG and increases the 02 affinity. These
findings are consistent with the fact that, despite the presence of carbamy-
lated hemoglobin, uremic patients do not present increased Hb-02
affinity.
Anemia was one of the major complications in end-stage renal
failure before the use of recombinant human erythropoietin. Yet
it was observed that uremic patients were able to tolerate a
remarkable degree of anemia without the appearance of incapac-
iting symptoms. This may be attributed to a decrease in oxygen
utilization because oxidative metabolism is reduced in skeletal
muscle despite normal intramyocyte oxidative performance [1].
This could also be related to an increase in oxygen delivery
resulting from the reduced hemoglobin-oxygen (Hb-02) affinity
observed in non-acidotic uremic patients [2, 3]. The decreased
affinity is linked to an increase in 2,3-diphosphoglycerate (2,3-
DPG) concentration, yet the increase is less pronounced in uremic
anemic subjects than in non-uremic ones with the same degree of
anemia [41.
However, the decrease in Hb-02 affinity observed in some
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uremic patients seems paradoxical since, because of the presence
of carbamylated hemoglobin in chronic renal failure [5, 61, the
affinity for oxygen should be increased. Indeed, carbamylation
results from the action of isocyanic acid, the active form of
cyanate formed by the spontaneous dissociation of urea in plasma.
Carbamylation occurs at the level of the NH2 terminal residues of
the a and f3 chains of hemoglobin and leads to an increase in
oxygen affinity [7]. This increase is likely associated with a
hindering of 2,3-DPG binding since the residues of 13chains are
involved in this binding [8]. The presence of carbamylated hemo-
globin in uremia [5, 61 therefore represents an apparent contra-
diction with the decrease in Hb-02 affinity observed in vivo in
some uremic patients.
This contradiction may be explained by our previous findings on
Hb-2,3-DPG binding in uremic patients [9, 10]. Using 31P NMR,
we showed that the spin-spin relaxation rate (lIT2) of 2,3-DPG
phosphorus atoms in uremic red blood cells (RBC) is faster than
in normal erythrocytes. This implies that 2,3-DPG-hemoglobin
binding is stronger in uremic patients and thus the oxygen delivery
should be facilitated. Because of its stronger binding, 2,3-DPG
would be able to compete with isocyanic acid at the level of Hb
NH2 terminal residues more efficiently. One may hypothesize that
the formation of carbamylated hemoglobin will be decreased and
that the increase in affinity for oxygen will be smaller.
This modification of 2,3-DPG-Hb binding in uremic RBC may
be due to a conformational change of the hemoglobin molecule.
Indeed, we showed that the spin-spin relaxation rates of water
protons in uremic erythrocytes were slower than in healthy
subjects [9]. Such a decrease could mean a reduced fraction of
Hb-bound water. In that case Hb would be less hydrated in uremic
patients than in normal subjects. These modifications may be
attributed to the presence of easily dialyzable factors, since
hemodialysis corrects the liT2 values [9].
The hypothesis is proposed that urea is at the origin of these
structural modifications of Hb. Indeed, urea is easily dialyzable
and is able to induce local structural changes in protein molecules.
It has been shown that marked structural changes also occur at the
concentrations seen in uremia [111. Ifsuch a hypothesis is verified
it would appear that, in uremia, urea would exert two opposing
effects: (1) a decreased oxygen affinity for Hb through a stronger
binding of 2,3-DPG to hemoglobin, and (2) an increased oxygen
affinity for Hb through the formation of the carbamylated form.
To verify this hypothesis, we show that urea modifies the
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spin-spin relaxation rates of 2,3-DPG phosphorus atoms in nor-
mal RBC and by measuring the P50 values of the intraerythrocytic
hemoglobin in the presence of urea. Preliminary results of this
study have already been published [121.
Methods
Materials
2,3 Diphosphoglycerate acid pentasodium salt (2,3-DPG) and
adenosine triphosphate (ATP) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). Magnesium chloride, potas-
sium chloride and urea were Aldrich products.
NMR measurements
Model solutions. The effect of urea on the relaxation of 2,3-DPG
phosphorus atoms might merely be due to a direct interaction of
these two molecules. To discard this possibility, the effect of urea
on 2,3-DPG relaxation was evaluated in an aqueous solution, the
so-called "model solution."
2,3-DPG (10 mM) was dissolved in Tris-HC1 containing ATP (2
mM), Mg2 (2.5 mM) and K (120 mM). Two final urea concen-
trations were used (40 m and 100 mM). The measured pH value
was adjusted to 7.30 0.03 using HC1 or NaOH. A small amount
of EDTA (about 10 mM) was added to remove any paramagnetic
impurities. The pH was measured using a Radiometer pH meter
before and after NMR measurements to verify the absence of
variation throughout the NMR experiments (± 0.05 pH unit).
Erythrocytes. Freshly drawn venous heparinized blood samples
were obtained from 20 healthy volunteers and 7 uremic patients
before and after a dialysis session. Samples were immediately
transferred to packed ice containers. To evaluate the effect of the
urea on 2,3-DPG relaxation in erythrocytes, samples were pre-
pared in various urea concentrations from a stock solution of urea
(6 M) also containing NaCl (140 mM) and KC1 (10 mM), immedi-
ately before centrifugation. The pH value of the stock solution
was adjusted to 7.40 0.03. Packed red blood cells were obtained
before NMR measurement by centrifugating (1500 x g) hepa-
rinized blood samples in hermetically sealed tubes at 4°C for 10
minutes. The plasma and buffy coat were removed by gentle
aspiration. The packed cell volume of about 90% was stored in
cold ice.
NMR. 31P NMR measurements were carried out at 30°C on
a Bruker AM 200 spectrometer (Service Interuniversitaire de
RMN, Faculté de Pharmacie, Marseille, France) operating at
81.02 MHz. Spectra were recorded in the pulsed Fourier
transform mode and broad-band protein noise decoupling was
used. Samples were placed in 10 m tubes with an inner coaxial
capillary containing an external reference 2H20 solution: meth-
ylene diphosphoric acid sodium salt (200 m in Tris-HCI, pH
8.9).
The spin-spin relaxation rate (lIT2) was measured using the
Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence: Dl to 90° -
(D2 to 180° - D2)n - FID. The accuracy in setting t, for the flip
angle is about 5% because of the nonhomogeneity in B1. How-
ever, the pulse sequences of the CPMG method largely eliminate
problems of pulse adjustment [13]. The relaxation delay (Dl) was
roughly fivefold longer than the spin-latice relaxation time (Ti;
2.5 0.5 s) of the sample. Delay D2 was set at 1 ms, a short value,
to eliminate the diffusion effect [13]. The number (n) of echoes
chosen to perform NMR experiments in about one hour was 8
(see below). The spectra were analyzed using integration mea-
surements of NMR signals with a 20% of experimental error, a
classical value for biological media.
The measured NMR signal M at -r ( = 2 x D2 x n) is:
M = M0exp(—-riT2)
where M0 is the initial signal intensity. Logarithms of experimen-
tal points were fitted with a linear regression to obtain liT2 values.
The 2,3-DPG relaxation rate, lIT2, is the weighted average of
the relaxation rates of 2,3-DPG in its different states: free and
bound with hemoglobin. Partial hydrolysis of 2,3-DPG in eryth-
rocytes modifies the equilibrium between these states and thus
leads to erroneous l/T2 measurements. Yet in a previous study we
showed that an NMR experiment would have to be performed in
about one hour to avoid the 2,3-DPG hydrolysis effect [9]. This
was not possible here because two or three urea concentrations
were used to evaluate the urea dose-effect, making the NMR too
long. Four or five hours elapsed before the last l/T2 measurement
was conducted; a partial hydrolysis of 2,3-DPG and ATP was
observed, resulting in a decrease in their NMR signals and an
increase in Pi NMR signal. This partial hydrolysis of 2,3-DPG was
between 20% and 30% (maxima observed), inducing an error of
about 14% on the measured 2,3-DPG relaxation rate l/T2 (cal-
culated from [9 and 14]). This error for the l/T2 values was
corrected when partial hydrolysis of 2,3-DPG was more than 5%.
Moreover, the Pi NMR signal is coupled with the P-2 NMR
signal of 2,3-DPG. Since hydrolysis increases the Pi concentration,
using the P-2 signal would lead to erroneous l/T2 values; there-
fore, only the P-3 NMR signal of 2,3-DPG was used. The samples
were randomly measured, and the first sample was introduced
once more at the end of the measurements to redetermine the
lIT2 value.
Intraeiythrocytic pH (pHi) determination, pHi was classically
determined by 31P NMR [15]. The chemical shift of 2,3-DPG
resonance was used to determine the pHi value as previously
described [16]. The determination was carried out with the first
spectrum of the CPMG pulse sequence.
P50 measurements
The action of urea on hemoglobin-oxygen affinity was deter-
mined on total blood samples from six healthy subjects immedi-
ately after the blood was collected. P50 was measured according to
a previously described technique [17]. pH was corrected using
Wranne's relationship [18]. The association constant of oxygen
(K) was calculated from Hill's relationship as follows:
So2
Log
—
02
= n log P0 + log K
where n is the slope of the Hill plot
02
Log1 —
02
with = 50%.
versus log P02 which determines the hemoglobin-hemoglobin
interactions. Hemoglobin and 2,3-DPG concentrations were mea-
sured with the cyanmethemoglobin technique and enzymic assay
(Boehringer), respectively.
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Fig. 1. An example of the NMR stacked plots
used to detennine lIT2 value by CPMG
method.
Three concentrations of urea (30, 60 and 120 mM) were tested.
These were obtained from the same stock solution as that used in
NMR measurements. P50 was determined using the same blood
sample with and without urea. Because of the time elapsed in
these experiments, we verified that pH, Hb and 2,3-DPG concen-
trations did not vary before each measurement.
Statistics
The mean values of experimental results are expressed with the
standard error of the mean (sEM). Comparative statistical analysis
of groups was performed using a distribution-free test for paired
data, the Wilcoxon t-test. For unpaired data the Mann-Whitney
U-test was used.
Results
In model solutions, urea had no significant effect on the
spin-spin relaxation rate (lIT2) of 2,3 DPG P-3 atom. The lIT2 P-3
value was 0.51 0.03 s-I without urea, 0.48 0.03 s-i and 0.56
0.04 s-i with 40 m and 100 mM urea, respectively. In erythro-
cytes, there was no significant variation in pHi value with or
without added urea: pHi = 7.27 0.02 without added urea (N =
16) and pHi = 7.30 0.01 with added urea (N = 26), all
concentrations considered together.
An example of l/T2 determination by the CPMG method is
shown in Figure 1 as NMR stacked plots. The corresponding
regression line is presented in Figure 2. The good value of r (r =
0.994) justified using a linear fit to calculate l/T2 values.
Table 1 lists the results obtained from normal erythrocytes with
various doses of urea. Relaxation rates significantly increased
when more than 10 mM urea was added. The increase remained
up to 60 mM. With a higher one (120 mM), the T2 value returned
to its initial value without urea. The scatter in the T2 values of
individual erythrocyte samples was large (Fig. 3). Hence the
modification induced by urea in a given sample was expressed as
a percentage of the value obtained with the same sample without
urea:
—0.5
0.0 0.1 0.2 0.3 0.4 0.5
T, ms
Fig. 2. Linear fit corresponding to the stacked plot used to calculate lIT2
value in Figure 1. lIT2 = 3.2 0.2 s; r = 0.994.
liT2 with urea added — 1/12without urea added
x 100
liT2 without urea added
Results are shown in Figure 4. The percentage increased up to
40%, remained constant to 60 mrvi and then returned to its initial
value with 120 m of urea.
Table 2 lists the results obtained with erythrocytes from uremic
patients before and after the hemodialysis session and with 30 mivi
urea added. We found two previously obtained results [9]. First,
1/12 values for uremic erythrocytes (5.1 0.4 s') before dialysis
0.OBOms
0.040 ms
0.004 ms
2.0
1.5
1.0
0.5
0.0
C
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Table 1. 2,3-DPG spin-spin relaxation rates l/T2 (s1) of P-3 atom for
various urea concentrations in erythrocytes from healthy volunteers
Number of
samples
.Without urea
added l/T2
Urea added .Wilcoxon
t-testUrea mM l/T2
4 3.6 0.1 5 3.4 0.1 NS N < 6
4 3.6 0.1 10 3.7 0.3 NS N < 6
8 3.2 0.3 20 4.2 0.2 P < 0.01
12 4.3 0.2 30 6.0 0.4 P < 0.01
10 3.5 0.3 40 4.8 0.4 P < 0.01
10 3.4 0.2 60 4.6 0.3 P < 0.01
6 4.0 0.4 120 4.1 0.4 NS
(NS = not significant)
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Fig. 4. Urea effect on lIT2 value erpressed as percentages.
Urea, mM
Table 2. 2,3-DPG spin-spin relaxation rates l/T2 (s) of P-3 atom in
erythrocytes from uremic patients
Samples before
dialysis
Sample after
dialysis
Wilcoxon
t-test
Samples after
dialysis
30 m urea
Wilcoxon
t-test
5.1 0.4
5.1 0.4
3.5 0.3
3.5 0.3
P < 0.05
4.6 0.3
4.6 0.3
P < 0.05
NS
2.5
A B C D E F G
Fig. 3. Scattering of lIT2 values in untreated e,ythrocytes. The mean values
are given with SEM (shaded area) and with SD (dashed line). Letters
correspond to erythrocytes before urea addition of 5, 10, 20, 30, 40, 60 and
120 mM, respectively.
were significantly higher than those of healthy controls (3.7 0.3
s1; Mann-Whitney U-test, P < 0.05; Table 1). Second, hemodi-
alysis corrected the lIT2 value; after the session the value (3.5
0.3 s') approached that of healthy subjects. Moreover, as in
normal RBC, the urea increased the P-3 spin-spin relaxation rate
(l/T2) by about 30%.
Table 3 shows the effect of urea on P50 and the association
constant of oxygen, K. With 30 mivi the action of urea was not
significant in the case of P50 but it significantly decreased K (P <
0.05). With 60 m no significant effect was observed for P50 and
K. With 120 m, urea significantly (P < 0.05) decreased P50 (26.6
vs. 28.0) and increased K (23.7 vs. 17.9).
Urea did not significantly modify n.
Discussion
Previously we showed that acidification of the intraerythrocytic
medium leads to an increase in the relaxation rates of the
2,3-DPG phosphorus atoms [9]. Our results revealed that the
NS = not significant.
addition of urea does not modify the intraerythrocytic pH.
Therefore, the increases in hF2 observed in normal and uremic
erythrocytes (Tables 1 and 2) are due to the effect of urea itself.
In model solutions urea does not modify the relaxation rate of
2,3-DPG phosphorus atoms, and thus a direct urea-2,3-DPG
interaction may be discarded. Hence the increases in spin-spin
relaxation rates shown in Tables 1 and 2 are consistent with a
modification by urea of the 2,3-DPG-Hb binding in normal and
uremic red blood cells.
The urea concentration in uremic patients before the hemodi-
alysis session was about 30 m. As shown in Table 1 and Figure
4 this concentration of urea increases the P-3 spin-Spin relaxation
rate (l/T2) of normal RBC by about 40%. Applying this percent-
age to the l/T2 mean value obtained in venous samples of healthy
subjects (Table 1) leads to a value of 5.2 s', close to the uremic
l/T2 values measured in the same conditions before dialysis
(Table 2). Moreover, the urea effect is also observed in uremic
RBC after dialysis. Adding urea to these erythrocytes leads to a
significant increase (P < 0.05) in 11I'2 (Table 2), which is not
significantly different from the l1I'2 observed before dialysis.
The urea effect therefore accounts for the difference between
normal and uremic erythrocytes and seems to make normal RBC
"uremic-like." This finding supports our hypothesis. In vitro it
appears that urea modifies the binding of 2,3-DPG to hemoglobin
in the same manner as that observed in uremic patients. Such a
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Table 3. P50 and association constant (K) mean values for various urea concentrations in erythrocytes from healthy volunteers
Urea
concentration
m
P50 mm Hg Wilcoxon
t-test
Kx 10-5
Wilcoxon
t-testWithout urea With ureaWithout urea With urea
30 26.1 1.1 25.9 1.1 NS 16.6 1.8 15.5 1.8 P < 0.05
60 26.6 0.7 26.3 0.6 NS 17.8 2.6 17.9 2.6 NS
120 28.0 0.5 26.6 0.4 P < 0.05 17.9 2.5 23.7 2.4 P < 0.05
NS = not significant.
modification probably occurs through local structural changes in
hemoglobin molecules. The changes may occur in uremic patients
since urea concentrations in the range of those observed in uremia
can induce specific changes in protein structure [11]. Thus the
effect of urea would lead to a decreased Hb-02 affinity related to
a stronger binding of 2,3-DPG. In fact, the decrease affinity would
be at least partially counteracted by the formation of urea-induced
carbamylated hemoglobin. The binding of cyanate to the terminal
amino acid of /3 chains [71 would hinder 2,3-DPG binding since
the /3 chains are involved in this binding [8]. Moreover, the
presence of a carbamyl group at the terminal region of the a chain
of hemoglobin [7] would preclude the formation of a salt bridge
between Val 1 and Arg 141 [8]. Thus the oxy-deoxy equilibrium
would be shifted towards the quaternary oxy conformation leading
to an increased oxygen affinity. The results shown in Tables I and
3, and Figure 4 support the above hypothesis, suggesting that
carbamylation may counteract the effect of the stronger binding of
2,3-DPG that urea induced. With low concentrations of urea, the
relaxation rate of the 2,3-DPG phosphorus atoms increases and
the 02 association constant slightly decreases. On the contrary,
with high concentrations of urea the "carbamylation" effect
predominates, as shown by the NMR results and the K value
obtained with 120 mM of urea. In this case urea does not modify
the relaxation rate, thus evidencing a less constraining binding of
2,3-DPG, whereas K increases.
Therefore, there may be a competition between two opposite
effects of urea: (a) through structural changes in the hemoglobin,
molecule it reinforces the 2,3-DPG-Hb binding and decreases the
02 affinity; and (b) through the carbamylation of hemoglobin, it
hinders the binding of diphosphoglycerate and increases the 02
affinity. The first effect seems to be more efficacious since it
slightly predominates with the lower urea concentrations, which
are similar to those observed in uremic patients.
While it is not easy to correlate an in vitro effect with an in vivo
action, our results nevertheless may be related to the apparent
contradiction that carbamylated hemoglobin, which is present in
chronic renal failure, should lead to an increase in Hb-02 affinity.
However, such an increase has never been observed in such
patients. Our findings showing a dual effect of urea might be
involved in this phenomenon.
Finally, it is generally admitted that plasma urea levels are
poorly correlated with uremic symptoms. This fact has been linked
with a lack of toxicity of urea or to a variable accumulation of
compounds which counteract its effects, as suggested by Lee et al
[11]. We propose another possible explanation, assigning a dual
effect to urea depending on its concentration.
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